DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,842,341 | +3.1% | 35,640 | -0.3% | 0.08% | -5.8% |
| Q2 2023 | $8,576,679 | -5.1% | 35,736 | -0.4% | 0.09% | +4.9% |
| Q1 2023 | $9,038,931 | +738.5% | 35,863 | -9.8% | 0.08% | +32.3% |
| Q4 2022 | $1,077,977 | -90.4% | 39,741 | -8.2% | 0.06% | -74.6% |
| Q3 2022 | $11,178,000 | +2.0% | 43,276 | +0.1% | 0.24% | +12.4% |
| Q2 2022 | $10,959,000 | -14.1% | 43,228 | -0.6% | 0.22% | +3.8% |
| Q1 2022 | $12,755,000 | -42.4% | 43,482 | -35.4% | 0.21% | -38.0% |
| Q4 2021 | $22,149,000 | -14.1% | 67,321 | -20.5% | 0.34% | -16.2% |
| Q3 2021 | $25,783,000 | +120.1% | 84,691 | +94.0% | 0.40% | +127.1% |
| Q2 2021 | $11,714,000 | +5.0% | 43,650 | -11.9% | 0.18% | -1.7% |
| Q1 2021 | $11,156,000 | -3.3% | 49,565 | -4.5% | 0.18% | -13.9% |
| Q4 2020 | $11,535,000 | +10.1% | 51,925 | +6.7% | 0.21% | -5.9% |
| Q3 2020 | $10,474,000 | +22.5% | 48,642 | +0.6% | 0.22% | +7.2% |
| Q2 2020 | $8,547,000 | +18.5% | 48,333 | -7.2% | 0.21% | -1.4% |
| Q1 2020 | $7,210,000 | -37.2% | 52,089 | -30.4% | 0.21% | -14.6% |
| Q4 2019 | $11,481,000 | -6.9% | 74,805 | -12.4% | 0.25% | -9.2% |
| Q3 2019 | $12,336,000 | +8.8% | 85,409 | +7.6% | 0.27% | +9.7% |
| Q2 2019 | $11,339,000 | +13.2% | 79,341 | +4.6% | 0.25% | +10.8% |
| Q1 2019 | $10,018,000 | +11.5% | 75,883 | -12.9% | 0.22% | +4.7% |
| Q4 2018 | $8,986,000 | +66.2% | 87,144 | +75.1% | 0.21% | +79.0% |
| Q3 2018 | $5,408,000 | +347.3% | 49,768 | +306.3% | 0.12% | +325.0% |
| Q2 2018 | $1,209,000 | +2.5% | 12,249 | +1.7% | 0.03% | 0.0% |
| Q1 2018 | $1,179,000 | -42.5% | 12,043 | -45.5% | 0.03% | -37.8% |
| Q4 2017 | $2,052,000 | -27.6% | 22,112 | -33.1% | 0.04% | -32.8% |
| Q3 2017 | $2,834,000 | -72.4% | 33,041 | -72.9% | 0.07% | -73.4% |
| Q2 2017 | $10,280,000 | +1.2% | 121,810 | +2.5% | 0.25% | -3.8% |
| Q1 2017 | $10,163,000 | +2.3% | 118,824 | -6.9% | 0.26% | +0.4% |
| Q4 2016 | $9,933,000 | +53.9% | 127,603 | +54.9% | 0.26% | +49.1% |
| Q3 2016 | $6,456,000 | +560.8% | 82,352 | +751.5% | 0.18% | +548.1% |
| Q2 2016 | $977,000 | +10.6% | 9,671 | +3.9% | 0.03% | +12.5% |
| Q1 2016 | $883,000 | +26.7% | 9,310 | +24.0% | 0.02% | +14.3% |
| Q4 2015 | $697,000 | +10.5% | 7,508 | +1.4% | 0.02% | +5.0% |
| Q3 2015 | $631,000 | +74.3% | 7,407 | +75.0% | 0.02% | +81.8% |
| Q2 2015 | $362,000 | -71.7% | 4,233 | -71.9% | 0.01% | -71.8% |
| Q1 2015 | $1,280,000 | -0.9% | 15,074 | 0.0% | 0.04% | -2.5% |
| Q4 2014 | $1,292,000 | +13.6% | 15,074 | +0.8% | 0.04% | +5.3% |
| Q3 2014 | $1,137,000 | +373.8% | 14,959 | +391.6% | 0.04% | +280.0% |
| Q2 2014 | $240,000 | -54.5% | 3,043 | -56.8% | 0.01% | -56.5% |
| Q1 2014 | $528,000 | -25.5% | 7,043 | -23.3% | 0.02% | -28.1% |
| Q4 2013 | $709,000 | -1.8% | 9,178 | -11.9% | 0.03% | 0.0% |
| Q3 2013 | $722,000 | +12.8% | 10,416 | +3.0% | 0.03% | +6.7% |
| Q2 2013 | $640,000 | – | 10,116 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |